Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Behcet’s disease

Rare Disease news

Rare Disease Video Recap—March 12, 2026

This biweekly Rare diseases video recap highlights regulatory decisions, orphan…

Rare Disease news

Rare Diseases Today—March 5, 2026

This is a weekly update in rare diseases, covering key regulatory actions,…

Immunology

Immunology Today—January 8, 2026

This Immunology update captures a broad range of developments, including…

Rare Disease news

Rare Diseases Weekly News - August 7th 2025

🧬 This Week in Rare Diseases: Europe’s R&D at Risk, AI Drug Discovery, New…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Oncology Today—March 23, 2026
AI in Healthcare and Digital Health Today—March 23, 2026

Tags

ACC/AHA antibiotics pipeline CABG CAP-1002 Chronic disease mortality conduction-system pacing cost reduction DIPS Arena Endogenex Enzalutamide FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists gout flares Haduvio Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer Imcivree Jaypirca JUST-AAV licensing live biotherapeutic product Metsera MicroRNAs naxtarubicin Nemolizumab NovaBridge OCALIVA Polypill PPMS RAP-219 Repinatrabit Rinvoq Rituximab Sensitive Skin Research Spikevax ST-920 Stanford Medicine substance use disorder Sutra Medical TG Therapeutics Transgene TYMLOS Ultra-Rare Lung Fibrosis Ver-A-T1D weight loss durability

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Oncology Today—March 23, 2026
AI in Healthcare and Digital Health Today—March 23, 2026

TAGS

ACC/AHA antibiotics pipeline CABG CAP-1002 Chronic disease mortality conduction-system pacing cost reduction DIPS Arena Endogenex Enzalutamide FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists gout flares Haduvio Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer Imcivree Jaypirca JUST-AAV licensing live biotherapeutic product Metsera MicroRNAs naxtarubicin Nemolizumab NovaBridge OCALIVA Polypill PPMS RAP-219 Repinatrabit Rinvoq Rituximab Sensitive Skin Research Spikevax ST-920 Stanford Medicine substance use disorder Sutra Medical TG Therapeutics Transgene TYMLOS Ultra-Rare Lung Fibrosis Ver-A-T1D weight loss durability

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy